Advertisements


Evolus investors frown as FDA declines to approve Botox rival

By Manas Mishra.....»»

Category: topSource: moneycentralMay 16th, 2018

Evolus investors frown as FDA declines to approve Botox rival

(Reuters) - U.S. he.....»»

Category: topSource: reutersMay 16th, 2018

Botox Rival Evolus Roars Back With 123% Rally Despite FDA Delay

Evolus Inc. is reaching new highs, shrugging off a delay of potential approval of its Botox-rivaling wrinkle treatment......»»

Category: topSource: moneycentralMay 24th, 2018

HRG Group investors approve merger with Spectrum Brands

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJul 13th, 2018

Spectrum Brands investors approve merger with HRG Group

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJul 13th, 2018

Achaogen stock slides 11% premarket after FDA declines to approve treatment for bloodstream infection

Shares of biotech Achaogen Inc. slid 11% in premarket trade Tuesday, after the company said it receiv.....»»

Category: topSource: marketwatchJun 26th, 2018

OPEC Announces Increase In Output, Declines To Provide Firm Number

Oil investors are cheering and oil prices are on the rise Friday following a production cap¬†announcement from OPEC. read more.....»»

Category: blogSource: benzingaJun 22nd, 2018

Evolus: Botox Competitor Poised For Massive Growth

Evolus: Botox Competitor Poised For Massive Growth.....»»

Category: topSource: seekingalphaJun 20th, 2018

The Federal Reserve has a glorious history of hurting investors

The U.S. central bank tends to raise interest rates too high, causing recessions and stock market declines......»»

Category: topSource: marketwatchJun 13th, 2018

Granite Construction: Layne Christensen investors approve acquisition

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 13th, 2018

Investors ready to resuscitate Johnson & Johnson"s ailing stock

NEW YORK (Reuters) - Johnson & Johnson shareholders have endured a painful year amid worries about prospects for its many businesses, but investors capitalizing on the stock's relatively cheap valuation may be set to apply a Band-Aid to the declines......»»

Category: topSource: reutersJun 11th, 2018

Deutsche Bank explores merger with Commerzbank: reports

Deutsche Bank AG's Chairman Paul Achleitner is considering a merger with rival Commerzbank AG and is speaking with top investors and government officials about the potential tie-up, Bloomberg repo.....»»

Category: topSource: marketwatchJun 8th, 2018

How Allergan went from a tiny but beloved Southern California eye care company to a dealmaking machine to falling out of grace with investors (AGN)

Reuters It's been a rocky year for Allergan, the pharmaceutical company best known for making Botox.  Investors have be.....»»

Category: topSource: businessinsiderJun 2nd, 2018

Market Snapshot: Stock market struggles for direction as bond yields rise; energy stocks rally

U.S. stocks were little changed on Thursday, with major indexes erasing mild early declines to turn positive, though tech stocks remained lower on the day and investors continued to watch a rise in bond yields......»»

Category: topSource: marketwatchMay 17th, 2018

Why Evolus Shares Are Getting Slammed

Evolus watched its shares come crashing down on Wednesday after the company announced that the FDA issued a Complete Response Letter for its treatment of glabellar lines, also known as frown lines,........»»

Category: blogSource: 247wallstMay 16th, 2018

Evolus: Is The Botox Knock Off Finally Here?

Evolus: Is The Botox Knock Off Finally Here?.....»»

Category: topSource: seekingalphaMay 14th, 2018

5 Top Stock Trades for Monday Morning

Investors took some time to digest the April non-farm payrolls report. After buying stocks like madmen, they seem to approve. Here are our top stock trades for Monday morning......»»

Category: topSource: moneycentralMay 7th, 2018

Cantor positive on Evolus, Revance on potential to take Botox share

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMay 7th, 2018

Gold futures end slightly higher, but tally a third straight weekly loss

Gold prices settled with a modest gain on Friday, but tallied a third straight week of declines as investors showed a lukewarm reaction to the monthly U.S. jobs repor.....»»

Category: topSource: marketwatchMay 4th, 2018

HSBC Q1 Pre-tax Earnings Down on High Costs, Stock Falls 4%

Rise in expenses primarily hurt HSBC's Q1 results. Also, the share buyback plan worth $2 billion was not enough for investors as the stock declines in pre-market trading. HSBC Holdings HSBC recorded firs.....»»

Category: smallbizSource: nytMay 4th, 2018

Global Stocks Fall After Fed Statement

Stocks in Europe and Asia mostly fell following declines in the U.S. as investors parsed the latest signals from the Federal Reserve......»»

Category: topSource: wsjMay 3rd, 2018